Advancing in vivo reprogramming with synthetic biology

被引：3
作者：
Islam, Farhana [1 ]
Lewis, Mitchell R. [1 ]
Craig, James [1 ]
Leyendecker, Peyton M. [1 ]
Deans, Tara L. [1 ]
机构：
[1] Univ Utah, Dept Biomed Engn, Salt Lake City, UT 84112 USA
来源：
CURRENT OPINION IN BIOTECHNOLOGY | 2024年 / 87卷
基金：
美国国家卫生研究院;
关键词：
CAR-T-CELLS; RNA; TRANSCRIPTION; SWITCH; PSEUDOURIDINE; EXPRESSION; CIRCUITS; PROTEINS; DELIVERY; FUTURE;
D O I：
10.1016/j.copbio.2024.103109
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
Reprogramming cells will play a fundamental role in shaping the future of cell therapies by developing new strategies to engineer cells for improved performance and higher-order physiological functions. Approaches in synthetic biology harness cells' natural ability to sense diverse signals, integrate environmental inputs to make decisions, and execute complex behaviors based on the health of the organism or tissue. In this review, we highlight strategies in synthetic biology to reprogram cells, and discuss how recent approaches in the delivery of modified mRNA have created new opportunities to alter cell function in vivo. Finally, we discuss how combining concepts from synthetic biology and the delivery of mRNA in vivo could provide a platform for innovation to advance in vivo cellular reprogramming.
引用
收藏
页数：9
相关论文
共 74 条
[1]   Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation [J].
Anderson, Bart R. ;
Muramatsu, Hiromi ;
Nallagatla, Subba R. ;
Bevilacqua, Philip C. ;
Sansing, Lauren H. ;
Weissman, Drew ;
Kariko, Katalin .
NUCLEIC ACIDS RESEARCH, 2010, 38 (17) :5884-5892
[2]   From gene switches to mammalian designer cells: present and future prospects [J].
Auslaender, Simon ;
Fussenegger, Martin .
TRENDS IN BIOTECHNOLOGY, 2013, 31 (03) :155-168
[3]   CAR T therapy beyond cancer: the evolution of a living drug [J].
Baker, Daniel J. ;
Arany, Zoltan ;
Baur, Joseph A. ;
Epstein, Jonathan A. ;
June, Carl H. .
NATURE, 2023, 619 (7971) :707-715
[4]   Self-amplifying RNA vaccines for infectious diseases [J].
Bloom, Kristie ;
van den Berg, Fiona ;
Arbuthnot, Patrick .
GENE THERAPY, 2021, 28 (3-4) :117-129
[5]   In vivo hematopoietic stem cell modification by mRNA delivery [J].
Breda, Laura ;
Papp, Tyler E. ;
Triebwasser, Michael P. ;
Yadegari, Amir ;
Fedorky, Megan T. ;
Tanaka, Naoto ;
Abdulmalik, Osheiza ;
Pavani, Giulia ;
Wang, Yongping ;
Grupp, Stephan A. ;
Chou, Stella T. ;
Ni, Houping ;
Mui, Barbara L. ;
Tam, Ying K. ;
Weissman, Drew ;
Rivella, Stefano ;
Parhiz, Hamideh .
SCIENCE, 2023, 381 (6656) :436-443
[6]   High-throughput enrichment and isolation of megakaryocyte progenitor cells from the mouse bone marrow [J].
Bush, Lucas M. ;
Healy, Connor P. ;
Marvin, James E. ;
Deans, Tara L. .
SCIENTIFIC REPORTS, 2021, 11 (01)
[7]   Biological Cells as Therapeutic Delivery Vehicles [J].
Bush, Lucas M. ;
Healy, Connor P. ;
Javdan, Shwan B. ;
Emmons, Jonathan C. ;
Deans, Tara L. .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2021, 42 (02) :106-118
[8]   The sound of silence: Transgene silencing in mammalian cell engineering [J].
Cabrera, Alan ;
Edelstein, Hailey I. ;
Glykofrydis, Fokion ;
Love, Kasey S. ;
Palacios, Sebastian ;
Tycko, Josh ;
Zhang, Meng ;
Lensch, Sarah ;
Shields, Cara E. ;
Livingston, Mark ;
Weiss, Ron ;
Zhao, Huimin ;
Haynes, Karmella A. ;
Morsut, Leonardo ;
Chen, Yvonne Y. ;
Khalil, Ahmad S. ;
Wong, Wilson W. ;
Collins, James J. ;
Rosser, Susan J. ;
Polizzi, Karen ;
Elowitz, Michael B. ;
Fussenegger, Martin ;
Hilton, Isaac B. ;
Leonard, Joshua N. ;
Bintu, Lacramioara ;
Galloway, Kate E. ;
Deans, Tara L. .
CELL SYSTEMS, 2022, 13 (12) :950-973
[9]   Transcription-dependent silencing of inducible convergent transgenes in transgenic mice [J].
Calero-Nieto, Fernando J. ;
Bert, Andrew G. ;
Cockerill, Peter N. .
EPIGENETICS & CHROMATIN, 2010, 3
[10]   mRNA vaccines for infectious diseases: principles, delivery and clinical translation [J].
Chaudhary, Namit ;
Weissman, Drew ;
Whitehead, Kathryn A. .
NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (11) :817-838
12345678